DMXE 40 mg pelletit (deoksymmetoksiatamiini)
DMXE-ominaisuudet
Synonyymi: Deoksimetoksetamiinihydrokloridi
CAS-numero: 681440-83-5
Kaava: 5-dehydro-1,3-kinodimetaani
Moolimassa: 103,14 g/mol
Puhtaus: >97%
€16.95 – €129.95Hintaluokka: €16.95 - €129.95
* Tämän sivun tiedot ovat yhteenveto, eikä niiden ole tarkoitus kattaa kaikkia saatavilla olevia tietoja tästä lääkkeestä. Ne eivät kata kaikkia mahdollisia käyttötarkoituksia, ohjeita, varotoimia, lääkkeiden yhteisvaikutuksia tai haittavaikutuksia, eivätkä ne korvaa terveydenhuollon ammattilaisen asiantuntemusta ja harkintaa.
DMXE (Deoxymethoxetamine) 40mg Pellets – Scientific Product Documentation
🔬Chemical Specifications
DMXE (2′-Oxo-PCE-d10) is a research chemical belonging to the arylcyclohexylamine class, structurally related to MXE (methoxetamine) and ketamine. These pellets are formulated for precise scientific research.
Core parameters:
IUPAC name : 2-(3,4-Dimethylphenyl)-2-(ethylamino)cyclohexanone
Molecular formula : C₁₆H₂₃NO
Molecular weight : 245.36 g/mol
Puhtaus : ≥98% (GC-MS analysis)
Shape : Round, 4mm diameter pellets
Color : Light beige to white
Solubility : 15 mg/ml in water (at 25°C)
🧪Tieteelliset sovellukset
Neuropharmacological research :
NMDA receptor antagonism studies
Sigma-1 receptor interaction assays
Behavioral Neuroscience :
Effects on learning behavior in laboratory animals
Dose-dependent dissociative effects
Psykofarmakologia :
Comparative studies with related dissociatives
Research into neuroplastic effects
⚖️Recommended Research Protocols
Experimental guidelines:
| Malli | Annostus | Frequency |
|---|---|---|
| In vitro | 10-50 μM | Single exposure |
| Small rodents | 5-20 mg/kg | 1x/day (max 3 days) |
| Primates | 1–5 mg/kg | Single dose |
*Note: Non-linear pharmacokinetics above 25 mg/kg*
⚠️Safety Profile & Risk Management
Toxicological data :
LD₅₀ (rat, oral): 320 mg/kg
NOAEL: 5 mg/kg/day (7-day study)
Side effect spectrum :
<10 mg: Subtle behavioral effects
10-30 mg: Motor incoordination
30 mg: Potential respiratory depression
Critical Interactions :
Dangerous : Opioids, GABA-ergics
Risky : Stimulants, MAO inhibitors
📊Quality Control & Analytical Data
HPLC purity : 98.5% (C18 column, 70:30 H₂O:MeCN)
Uniformity : ±5% weight deviation (n=20 pellets)
Disintegration time : <15 minutes (in simultaneous gastric juice)
Vakaustiedot :
Shelf life: 24 months at 15-25°C
Moisture sensitivity: <0.5% weight gain (93% RH)
❓Frequently Asked Research Questions
Q1: What is the mechanism of action?
A: Primary NMDA receptor antagonism with secondary dopamine reuptake inhibition.
Q2: How does the potency compare to ketamine?
A: ~0.6x the potency of ketamine but a longer half-life (4-6 hours).
Q3: Are there neurotoxic risks?
A: Olney’s lesions were not observed at <50 mg/kg (rat study).
Q4: What is the optimal storage method?
A: In the original packaging at 15-25°C, protected from moisture.
📌Research limitations
Limited data on chronic administration
Unknown effects on glutamate transmission
Variable biotransformation between species
🔍Conclusion for Researchers
DMXE 40mg pellets offer a standardized formulation for precise dissociative research, with consistent dose delivery and good stability. The pellet form facilitates quantitative administration in animal studies.
Scientific disclaimer: This product is intended solely for in vitro research and authorized preclinical studies. Not for human use. All experiments must comply with applicable ethical guidelines and local regulations. Please be aware of the special status of psychoactive research substances in your jurisdiction.
